Viewing Study NCT04432402


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-02-28 @ 8:31 PM
Study NCT ID: NCT04432402
Status: UNKNOWN
Last Update Posted: 2020-06-16
First Post: 2020-06-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module